Synapdx Corp.

WALTHAM, Massachusetts, June 1, 2010 - SynapDx Corp., a new company focused on developing and commercializing diagnostic testing for the early detection of autism, announced the completion of a US$9 million Series A financing by Bain Capital Ventures, General Catalyst Partners, and North Bridge Venture Partners.